SIFI

On our Social Channels

From our News Center

Knight Therapeutics and SIFI S.p.A. Announce Approval of NETILDEX® in Canada

23 October

Knight Therapeutics Inc. (TSX: GUD) (“Knight”), a leading Canadian specialty pharmaceutical company, and SIFI S.p.A. (“SIFI”), a prominent Italian Eye Care company, today...

> read on

SIFI appoints new Country Manager for Italy

20 September

As of today Fabrizio Folco assumes management of the company's organization for the Italian market SIFI, Italian leader in the development and marketing of innovative...